Skip to main content
Journal of Nanobiotechnology logoLink to Journal of Nanobiotechnology
. 2022 Oct 12;20:443. doi: 10.1186/s12951-022-01645-w

Retraction Note to: A stepwise-targeting strategy for the treatment of cerebral ischemic stroke

Jingbo Hu 1,✉,#, Xueying Tan 2,#, Dongwei Wang 1, Yixuan Li 1, Hongze Liang 1, Jiejun Peng 3,, Fengyan Li 2, Quan Zhou 4, Peiwu Geng 4, Shuanghu Wang 4, Yue Yu 5, Jin Liu 4,
PMCID: PMC9554990  PMID: 36224657

Retraction to: Journal of Nanobiotechnology (2021) 19:371 10.1186/s12951-021-01118-6

The Editors-in-Chief have retracted this article. After publication, the following concerns were raised:

  • in Fig. 3, the Heart/Saline panel and Heart/Micelle panels partially overlap, respectively, with the Heart/HA-CUR panel and Heart/CUR panel in Fig. S2 in [1];

  • in Fig. 3, the Heart/Saline and Heart/Micelles panels partially overlap, respectively, with Heart/DEX-SS-IND and Heart/Saline panel in Fig. 7 in [2];

  • in Fig. 4a, the TGN/cy3 micelles panel in 2.0 h line overlaps with the SA-DEX-CUR panel in the e-Selectin line in Fig. 4 in [3];

  • in Fig. 5D, panels H2O2 and H2O2 + TPP-MLT overlap, respectively, with panels PTX and FA@PPMoV@PTX in Fig. 4B in [4].

Following these concerns author Jingbo Hu contacted the journal requesting a retraction. They did not respond to the editor's request to share original data. The Editors-in-Chief therefore no longer have confidence in the integrity of the data in this article.

Jingbo Hu agrees to this retraction. The other authors have not responded to any correspondence from the editor/publisher about this retraction.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Jingbo Hu and Xueying Tan contributed equally to this paper

Contributor Information

Jingbo Hu, Email: hujingbo@nbu.edu.cn.

Jiejun Peng, Email: pengjiejun@nbu.edu.cn.

Jin Liu, Email: liujin-614@163.com.

References

  • 1.Hu J, Li Sh, Kang X, Qi J, Wu J, Wang X, Xu X, Ying X, Jiang S, You J, Du Y. CD44-targeted hyaluronic acid-curcumin prodrug protects renal tubular epithelial cell survival from oxidative stress damage. Carbohyd Polym. 2018;193:268–280. doi: 10.1016/j.carbpol.2018.04.011. [DOI] [PubMed] [Google Scholar]
  • 2.Wang S, Tan X, Li S, Zhou Y, Geng P, Hua A, Deng A, Yu Z. Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance. Oncotarget. 2017;8(67):111281. doi: 10.18632/oncotarget.22781. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 3.Hu JB, Liu D, Qi J, Lu KJ, Jin FY, Ying XY, You J, Du YZ. An E-selectin targeting and MMP-2-responsive dextran–curcumin polymeric prodrug for targeted therapy of acute kidney injury. Biomater Sci. 2018;6(12):3397–3409. doi: 10.1039/C8BM00813B. [DOI] [PubMed] [Google Scholar]
  • 4.Peng J, Yin Y, Liang H, Lu Y, Zheng H, Wu G, Rao S, Chen J, Yan F, Hu J. Tumor microenvironment responsive pepper mild mottle virus-based nanotubes for targeted delivery and controlled release of paclitaxel. Front Bioeng Biotechnol. 2021;9:763661. doi: 10.3389/fbioe.2021.763661. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Nanobiotechnology are provided here courtesy of BMC

RESOURCES